Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-655.51%
operating margin TTM
-798.41%
revenue TTM
245.54 Million
revenue per share TTM
2.3$
valuation ratios | |
|---|---|
| pe ratio | -26.34 |
| peg ratio | -9.40 |
| price to book ratio | 3.12 |
| price to sales ratio | 174.00 |
| enterprise value multiple | -19.09 |
| price fair value | 3.12 |
profitability ratios | |
|---|---|
| gross profit margin | 100.0% |
| operating profit margin | -798.41% |
| pretax profit margin | -656.17% |
| net profit margin | -655.51% |
| return on assets | -10.51% |
| return on equity | -11.52% |
| return on capital employed | -13.92% |
liquidity ratio | |
|---|---|
| current ratio | 9.14 |
| quick ratio | 9.03 |
| cash ratio | 0.56 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 0.00 |
| operating cycle | 0.00 |
| days of payables outstanding | 0.00 |
| cash conversion cycle | 0.00 |
| receivables turnover | 0.82 |
| payables turnover | 0.00 |
| inventory turnover | 0.00 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.02 |
| debt equity ratio | 0.03 |
| long term debt to capitalization | 0.02 |
| total debt to capitalization | 0.02 |
| interest coverage | 0.00 |
| cash flow to debt ratio | -9.61 |
cash flow ratios | |
|---|---|
| free cash flow per share | -1.10 |
| cash per share | 3.21 |
| operating cash flow per share | -0.97 |
| free cash flow operating cash flow ratio | 1.13 |
| cash flow coverage ratios | -9.61 |
| short term coverage ratios | -53.17 |
| capital expenditure coverage ratio | -7.47 |
Frequently Asked Questions
When was the last time POINT Biopharma Global Inc. (NASDAQ:PNT) reported earnings?
POINT Biopharma Global Inc. (PNT) published its most recent earnings results on 13-11-2023.
What is POINT Biopharma Global Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. POINT Biopharma Global Inc. (NASDAQ:PNT)'s trailing twelve months ROE is -11.52%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. POINT Biopharma Global Inc. (PNT) currently has a ROA of -10.51%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did PNT's net profit margin stand at?
PNT reported a profit margin of -655.51% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is PNT's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 9.14 in the most recent quarter. The quick ratio stood at 9.03, with a Debt/Eq ratio of 0.03.